Literature DB >> 20412754

The long and winding road to understanding and conquering type 1 diabetes.

Pere Santamaria1.   

Abstract

Autoimmune diseases with high population prevalence such as type 1 diabetes (T1D) develop as a result of ill-defined interactions between putative environmental triggers and a constellation of genetic elements scattered throughout the genome. In T1D, these interactions somehow trigger a loss of tolerance to pancreatic beta cells, manifested in the form of a chronic autoimmune response that mobilizes virtually every cell type of the immune system and progressively erodes the host's beta cell mass. The five accompanying review articles focus on key areas of T1D research, ranging from genetics and pathogenesis to prediction and therapy. Here, I attempt to integrate and bring into focus the most salient points of these reviews in the context of other findings, with an emphasis on identifying knowledge gaps and research opportunities. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412754     DOI: 10.1016/j.immuni.2010.04.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  38 in total

Review 1.  Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?

Authors:  Xavier Clemente-Casares; Sue Tsai; Yang Yang; Pere Santamaria
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

2.  A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Authors:  Jamal S Lewis; Natalia V Dolgova; Ying Zhang; Chang Qing Xia; Clive H Wasserfall; Mark A Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Clin Immunol       Date:  2015-04-02       Impact factor: 3.969

3.  Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes.

Authors:  Zahra Azhir; Fariba Dehghanian; Zohreh Hojati
Journal:  Mol Biol Rep       Date:  2018-09-07       Impact factor: 2.316

4.  Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.

Authors:  Li-Fen Lee; Kathryn Logronio; Guang Huan Tu; Wenwu Zhai; Irene Ni; Li Mei; Jeanette Dilley; Jessica Yu; Arvind Rajpal; Colleen Brown; Charles Appah; Sherman Michael Chin; Bora Han; Timothy Affolter; John C Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 5.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

6.  Bridge between type 1 diabetes in mouse and man.

Authors:  Defu Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

7.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

8.  IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice.

Authors:  Hirokazu Fujimoto; Tetsuaki Hirase; Yoshiyuki Miyazaki; Hiromitsu Hara; Noriko Ide-Iwata; Ai Nishimoto-Hazuku; Christiaan J M Saris; Hiroki Yoshida; Koichi Node
Journal:  Am J Pathol       Date:  2011-09-15       Impact factor: 4.307

9.  Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.

Authors:  Anna Moser; Hsiang-Ting Hsu; Peter van Endert
Journal:  F1000 Biol Rep       Date:  2010-10-21

10.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.